logo
Select company
Select metric
$ 0Interest Expense
VS
Market
69
Sector
59
Industry
47
History
91
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 1.27M
3/31/2024$ 2.02M
12/31/2023$ 2.83M
9/30/2023$ 3.64M
6/30/2023$ 3.17M
3/31/2023$ 3.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 1.18M.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Int. Exp. has been $ 2.03M.
  • The median Int. Exp. for CARTESIAN THERAPEUTICS INC during this period was $ 2.67M
  • CARTESIAN THERAPEUTICS INC reached its highest Int. Exp. over the past 5 years at $ 3.64M.
  • The lowest Int. Exp. recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ 0

CARTESIAN THERAPEUTICS INC's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
HUMA : HUMACYTE INC $ 10.49MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ 8MMREO : MEREO BIOPHARMA GROUP PLC $ 932KINBX : INHIBRX BIOSCIENCES INC $ 5.83MCRDF : CARDIFF ONCOLOGY INC $ 0BTAI : BIOXCEL THERAPEUTICS INC $ 16.04MCATX : PERSPECTIVE THERAPEUTICS INC $ 243KADVM : ADVERUM BIOTECHNOLOGIES INC $ 0SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 0LSTA : LISATA THERAPEUTICS INC $ 0

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

RNAC - Interest Expense, Last 5 years

$ 0

Minimum

Sep 30, 2024

$ 3.64M

Maximum

Sep 30, 2023

$ 2.03M

Average

$ 2.67M

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.75M with a standard deviation of $ 5.5M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.72K
min$ -15.41M
max$ 22.87M
average$ 2.75M
median$ 17K
std$ 5.5M